Zacks: Brokerages Anticipate MINDBODY Inc (MB) to Post -$0.07 Earnings Per Share

Equities research analysts expect MINDBODY Inc (NASDAQ:MB) to report earnings per share (EPS) of ($0.07) for the current fiscal quarter, Zacks Investment Research reports. Eight analysts have made estimates for MINDBODY’s earnings. The highest EPS estimate is ($0.06) and the lowest is ($0.08). MINDBODY reported earnings of $0.01 per share during the same quarter last year, which would indicate a negative year over year growth rate of 800%. The company is scheduled to report its next earnings results on Thursday, October 25th.

According to Zacks, analysts expect that MINDBODY will report full-year earnings of ($0.13) per share for the current fiscal year, with EPS estimates ranging from ($0.15) to ($0.10). For the next year, analysts anticipate that the firm will post earnings of $0.02 per share, with EPS estimates ranging from ($0.08) to $0.06. Zacks’ earnings per share averages are a mean average based on a survey of sell-side research analysts that that provide coverage for MINDBODY.

MINDBODY (NASDAQ:MB) last announced its earnings results on Tuesday, July 31st. The technology company reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.18) by ($0.04). MINDBODY had a negative return on equity of 6.83% and a negative net margin of 11.85%. The company had revenue of $61.61 million during the quarter, compared to analysts’ expectations of $60.48 million.

Several research analysts recently issued reports on MB shares. DA Davidson upped their target price on shares of MINDBODY to $48.00 and gave the stock a “buy” rating in a research report on Wednesday, September 19th. Credit Suisse Group lowered their price target on shares of MINDBODY from $41.00 to $38.00 and set a “neutral” rating for the company in a research note on Wednesday, August 1st. Wells Fargo & Co assumed coverage on shares of MINDBODY in a research note on Friday, September 7th. They issued an “outperform” rating and a $45.00 price target for the company. William Blair assumed coverage on shares of MINDBODY in a research note on Wednesday, September 26th. They issued a “market perform” rating for the company. Finally, BidaskClub raised shares of MINDBODY from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, September 11th. Five analysts have rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of $40.20.

NASDAQ:MB traded down $0.04 during midday trading on Friday, hitting $34.55. The company had a trading volume of 800,791 shares, compared to its average volume of 576,140. MINDBODY has a 52-week low of $28.00 and a 52-week high of $45.50. The firm has a market capitalization of $1.94 billion, a PE ratio of -113.97 and a beta of -0.20. The company has a debt-to-equity ratio of 0.86, a quick ratio of 9.61 and a current ratio of 9.61.

In other news, Director Adam L. Miller acquired 3,000 shares of the stock in a transaction dated Tuesday, August 14th. The stock was purchased at an average cost of $35.66 per share, with a total value of $106,980.00. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Richard Lee Stollmeyer sold 17,739 shares of the company’s stock in a transaction dated Wednesday, August 1st. The shares were sold at an average price of $34.61, for a total transaction of $613,946.79. The disclosure for this sale can be found here. Insiders sold 66,055 shares of company stock valued at $2,473,395 over the last three months. 6.02% of the stock is currently owned by insiders.

Several large investors have recently modified their holdings of the company. Nelson Roberts Investment Advisors LLC raised its stake in shares of MINDBODY by 1.1% during the second quarter. Nelson Roberts Investment Advisors LLC now owns 123,901 shares of the technology company’s stock valued at $4,783,000 after acquiring an additional 1,325 shares during the last quarter. Commonwealth Equity Services LLC raised its stake in shares of MINDBODY by 16.5% during the first quarter. Commonwealth Equity Services LLC now owns 9,466 shares of the technology company’s stock valued at $368,000 after acquiring an additional 1,343 shares during the last quarter. Rhumbline Advisers raised its stake in shares of MINDBODY by 4.4% during the second quarter. Rhumbline Advisers now owns 41,030 shares of the technology company’s stock valued at $1,584,000 after acquiring an additional 1,737 shares during the last quarter. Schwab Charles Investment Management Inc. raised its stake in shares of MINDBODY by 1.2% during the first quarter. Schwab Charles Investment Management Inc. now owns 173,190 shares of the technology company’s stock valued at $6,738,000 after acquiring an additional 2,031 shares during the last quarter. Finally, Arthur M. Cohen & Associates LLC raised its stake in shares of MINDBODY by 27.8% during the second quarter. Arthur M. Cohen & Associates LLC now owns 11,500 shares of the technology company’s stock valued at $444,000 after acquiring an additional 2,500 shares during the last quarter. 96.82% of the stock is owned by hedge funds and other institutional investors.

MINDBODY Company Profile

MINDBODY, Inc operates a cloud-based business management software and payments platform for the small and medium-sized businesses in the wellness services industry. Its platform enables businesses to run, market, and build scheduling and online booking, performance tracking, staff management, client relationship management, integrated payment processing, retail point-of-sale, purchase tracking, inventory, hardware integration, analytics and reporting, branded Web, mobility, social integration, client acquisition dashboard, security and compliance, and integration with other cloud-based partners for yoga, Pilates, indoor cycling, group and personal training, boutique fitness, salons, spas, and integrative health businesses.

Featured Article: Asset Allocation and Your Retirement

Get a free copy of the Zacks research report on MINDBODY (MB)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for MINDBODY (NASDAQ:MB)

Receive News & Ratings for MINDBODY Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MINDBODY and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply